The relationship between MTHFR variants and thrombosis risk is a complex issue, but current evidence points to no association between the most common variants and an elevated risk.
The advent of approved treatments doesn’t change the need for a team approach to this challenging demyelinating autoimmune disease.
Haploidentical bone marrow transplantation may help increase the donor pool for patients with sickle cell disease. A recent study reports two-year event-free survival comparable to matched sibling donor myeloablative transplant.
The updated guidance also introduces flexibility in use of risk scores to estimate thromboembolic risk and strengthens endorsements for catheter ablation and left atrial appendage occlusion devices.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
New research indicates that combined liver transplant and cardiac surgery may be feasible in highly selected patients, and Cleveland Clinic physicians have created an algorithm to better identify which patients could benefit most.
Cleveland Clinic hematologist Faiz Anwer, MD, explains the gene editing technology CRISPR.
Three pediatric gastroenterologists discuss advances in their diagnostic and interventional toolkits for esophageal dysfunction.
A collaborative and multidisciplinary approach was necessary to treat a rare sinonasal adenocarcinoma.
Through strategic planning and preparedness, Cleveland Clinic’s recovery readiness strategy addresses the necessary safeguards to protect its mission-critical digital assets and network.
Male factors play a role in about half of all infertility cases, yet men often are not evaluated while their partner goes through fertility treatments. This Q&A with urologist Scott Lundy, MD, PhD, addresses how to advocate for patients.